Doxa AB
STO:DOXA

Watchlist Manager

Doxa AB

STO:DOXA

Watchlist

Discount Rate

Price: 1.092 SEK 2.25% Market Closed

Market Cap: 1.4B SEK

Have any thoughts about
Doxa AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 1.092 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DOXA Alert

Doxa AB

1.092

+0.024 (+2.25%)

52 Week Range	1.036 3.74
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Doxa AB

What unique competitive advantages
does Doxa AB hold over its rivals?

What risks and challenges
does Doxa AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Doxa AB.

What unique competitive advantages
does Doxa AB hold over its rivals?

What risks and challenges
does Doxa AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Doxa AB.

Provide P/S
for Doxa AB.

Provide P/E
for Doxa AB.

Provide P/OCF
for Doxa AB.

Provide P/FCFE
for Doxa AB.

Provide P/B
for Doxa AB.

Provide EV/S
for Doxa AB.

Provide EV/GP
for Doxa AB.

Provide EV/EBITDA
for Doxa AB.

Provide EV/EBIT
for Doxa AB.

Provide EV/OCF
for Doxa AB.

Provide EV/FCFF
for Doxa AB.

Provide EV/IC
for Doxa AB.

Compare the intrinsic valuations
of Doxa AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Doxa AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Doxa AB compared to its peers.

Compare the P/E ratios
of Doxa AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Doxa AB with its peers.

Analyze the financial leverage
of Doxa AB compared to its main competitors.

Show all profitability ratios
for Doxa AB.

Provide ROE
for Doxa AB.

Provide ROA
for Doxa AB.

Provide ROIC
for Doxa AB.

Provide ROCE
for Doxa AB.

Provide Gross Margin
for Doxa AB.

Provide Operating Margin
for Doxa AB.

Provide Net Margin
for Doxa AB.

Provide FCF Margin
for Doxa AB.

Show all solvency ratios
for Doxa AB.

Provide D/E Ratio
for Doxa AB.

Provide D/A Ratio
for Doxa AB.

Provide Interest Coverage Ratio
for Doxa AB.

Provide Altman Z-Score Ratio
for Doxa AB.

Provide Quick Ratio
for Doxa AB.

Provide Current Ratio
for Doxa AB.

Provide Cash Ratio
for Doxa AB.

What is the historical Revenue growth
over the last 5 years for Doxa AB?

What is the historical Net Income growth
over the last 5 years for Doxa AB?

What is the current Free Cash Flow
of Doxa AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Doxa AB.

DOXA

Balance Sheet

Total Liabilities & Equity

Doxa AB
Total Liabilities & Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Doxa AB
Total Liabilities & Equity Peer Comparison

Comparables:

OSSD

XVIVO

BACTI B

VIMIAN

S2M

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company		Total Liabilities & Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
D	Doxa AB STO:DOXA	Total Liabilities & Equity kr3.5B	CAGR 3-Years 236%	CAGR 5-Years 180%	CAGR 10-Years 74%
O	OssDsign AB STO:OSSD	Total Liabilities & Equity kr356.4m	CAGR 3-Years 13%	CAGR 5-Years 37%	CAGR 10-Years N/A
	Xvivo Perfusion AB STO:XVIVO	Total Liabilities & Equity kr2.3B	CAGR 3-Years 26%	CAGR 5-Years 29%	CAGR 10-Years 27%
	Bactiguard Holding AB STO:BACTI B	Total Liabilities & Equity kr662.2m	CAGR 3-Years -1%	CAGR 5-Years 2%	CAGR 10-Years N/A
V	Vimian Group AB STO:VIMIAN	Total Liabilities & Equity €996.5m	CAGR 3-Years 22%	CAGR 5-Years N/A	CAGR 10-Years N/A
S	S2Medical AB (publ) STO:S2M	Total Liabilities & Equity kr17.6m	CAGR 3-Years -15%	CAGR 5-Years -15%	CAGR 10-Years N/A

What is Doxa AB's Total Liabilities & Equity?

Total Liabilities & Equity
3.5B SEK

Based on the financial report for Jun 30, 2024, Doxa AB's Total Liabilities & Equity amounts to 3.5B SEK.

What is Doxa AB's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 10Y
74%

Over the last year, the Total Liabilities & Equity growth was 23%. The average annual Total Liabilities & Equity growth rates for Doxa AB have been 236% over the past three years , 180% over the past five years , and 74% over the past ten years .

Doxa AB
STO:DOXA

Doxa AB
Total Liabilities & Equity

Doxa AB
Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

See Also

What is Doxa AB's Total Liabilities & Equity?

Total Liabilities & Equity
3.5B SEK

What is Doxa AB's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 10Y
74%

Company

Help

Tools

Stocks

Doxa AB STO:DOXA

Doxa AB Total Liabilities & Equity

Doxa AB Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis Latest Figures & CAGR of Competitors

See Also

What is Doxa AB's Total Liabilities & Equity? Total Liabilities & Equity 3.5B SEK

What is Doxa AB's Total Liabilities & Equity growth rate? Total Liabilities & Equity CAGR 10Y 74%

Company

Help

Tools

Stocks

Doxa AB
STO:DOXA

Doxa AB
Total Liabilities & Equity

Doxa AB
Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

What is Doxa AB's Total Liabilities & Equity?

Total Liabilities & Equity
3.5B SEK

What is Doxa AB's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 10Y
74%